DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,699,652 | -12.6% | 47,157 | -15.4% | 0.35% | +1.5% |
| Q2 2023 | $13,380,720 | -4.7% | 55,753 | +0.1% | 0.34% | -8.0% |
| Q1 2023 | $14,036,864 | -4.5% | 55,693 | +0.5% | 0.37% | -9.0% |
| Q4 2022 | $14,704,003 | +3.8% | 55,399 | +1.0% | 0.41% | -2.6% |
| Q3 2022 | $14,169,000 | +3.5% | 54,858 | +1.6% | 0.42% | +28.7% |
| Q2 2022 | $13,690,000 | -12.7% | 53,998 | +1.0% | 0.33% | +7.2% |
| Q1 2022 | $15,688,000 | -12.0% | 53,483 | -1.3% | 0.31% | -7.0% |
| Q4 2021 | $17,822,000 | +7.5% | 54,168 | -0.5% | 0.33% | -3.5% |
| Q3 2021 | $16,574,000 | +12.5% | 54,442 | -0.8% | 0.34% | +14.0% |
| Q2 2021 | $14,732,000 | +18.6% | 54,898 | -0.5% | 0.30% | +10.7% |
| Q1 2021 | $12,419,000 | -1.7% | 55,176 | -3.0% | 0.27% | -5.6% |
| Q4 2020 | $12,632,000 | +0.9% | 56,866 | -2.2% | 0.29% | -5.9% |
| Q3 2020 | $12,523,000 | +20.5% | 58,159 | -1.1% | 0.30% | +14.3% |
| Q2 2020 | $10,395,000 | +18.4% | 58,783 | -7.3% | 0.27% | +7.3% |
| Q1 2020 | $8,781,000 | -11.3% | 63,439 | -1.6% | 0.25% | +13.8% |
| Q4 2019 | $9,897,000 | +3.5% | 64,486 | -2.6% | 0.22% | -0.5% |
| Q3 2019 | $9,562,000 | +1.7% | 66,202 | +0.6% | 0.22% | +0.5% |
| Q2 2019 | $9,403,000 | +9.4% | 65,793 | +1.1% | 0.22% | +6.3% |
| Q1 2019 | $8,595,000 | +31.5% | 65,104 | +2.7% | 0.20% | +17.1% |
| Q4 2018 | $6,537,000 | -3.4% | 63,391 | +1.8% | 0.18% | +8.7% |
| Q3 2018 | $6,765,000 | +10.4% | 62,263 | +0.2% | 0.16% | +5.9% |
| Q2 2018 | $6,130,000 | +1.6% | 62,119 | +0.8% | 0.15% | -1.9% |
| Q1 2018 | $6,033,000 | +5.4% | 61,615 | -0.1% | 0.16% | +9.9% |
| Q4 2017 | $5,723,000 | +7.9% | 61,661 | -0.3% | 0.14% | +2.2% |
| Q3 2017 | $5,304,000 | +2.2% | 61,829 | +0.6% | 0.14% | +0.7% |
| Q2 2017 | $5,189,000 | -1.2% | 61,486 | +0.2% | 0.14% | -2.8% |
| Q1 2017 | $5,251,000 | +10.7% | 61,392 | +0.7% | 0.14% | +11.0% |
| Q4 2016 | $4,745,000 | +0.3% | 60,953 | +1.0% | 0.13% | -0.8% |
| Q3 2016 | $4,733,000 | -20.5% | 60,374 | +2.4% | 0.13% | -23.4% |
| Q2 2016 | $5,956,000 | +7.8% | 58,971 | +1.2% | 0.17% | +5.0% |
| Q1 2016 | $5,526,000 | +3.3% | 58,255 | +1.1% | 0.16% | 0.0% |
| Q4 2015 | $5,351,000 | +12.5% | 57,611 | +3.2% | 0.16% | +1.9% |
| Q3 2015 | $4,756,000 | -4.7% | 55,812 | -4.2% | 0.16% | 0.0% |
| Q2 2015 | $4,989,000 | +2.5% | 58,288 | +1.7% | 0.16% | +9.9% |
| Q1 2015 | $4,866,000 | +2.6% | 57,316 | +3.5% | 0.14% | -3.4% |
| Q4 2014 | $4,745,000 | +16.0% | 55,360 | +2.9% | 0.15% | +5.8% |
| Q3 2014 | $4,089,000 | -2.9% | 53,818 | +0.6% | 0.14% | -2.8% |
| Q2 2014 | $4,211,000 | +5.3% | 53,487 | +0.3% | 0.14% | -1.4% |
| Q1 2014 | $4,000,000 | -2.7% | 53,332 | +0.2% | 0.14% | -6.5% |
| Q4 2013 | $4,109,000 | +11.0% | 53,229 | -0.3% | 0.16% | +4.0% |
| Q3 2013 | $3,701,000 | +14.0% | 53,397 | +4.1% | 0.15% | +12.9% |
| Q2 2013 | $3,247,000 | +5.2% | 51,292 | +3.3% | 0.13% | +4.8% |
| Q1 2013 | $3,087,000 | +10.6% | 49,667 | -0.5% | 0.13% | +1.6% |
| Q4 2012 | $2,791,000 | -1.3% | 49,922 | -2.6% | 0.12% | -1.6% |
| Q3 2012 | $2,828,000 | +8.1% | 51,274 | +2.1% | 0.13% | +2.4% |
| Q2 2012 | $2,616,000 | -7.4% | 50,231 | -0.5% | 0.12% | -3.1% |
| Q1 2012 | $2,826,000 | +20.9% | 50,461 | +1.5% | 0.13% | +6.7% |
| Q4 2011 | $2,338,000 | +12.9% | 49,700 | +0.6% | 0.12% | 0.0% |
| Q3 2011 | $2,071,000 | – | 49,389 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |